Literature DB >> 8342729

Mandating vitamin K prophylaxis for newborns in New York State.

T H Tulchinsky1, M M Patton, L A Randolph, M R Meyer, J V Linden.   

Abstract

New York State's infant deaths and hospitalizations attributed to hemorrhagic disease of the newborn and other neonatal hemorrhagic conditions were reviewed. In 65% of 34 deaths reviewed, vitamin K was not documented as given or was given only after the onset of hemorrhage. Vitamin K was not included in standing orders in any of 22 hospitals contacted. As a result of this review, vitamin K prophylaxis was made a mandatory newborn care procedure in the State Public Health Code.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8342729      PMCID: PMC1695173          DOI: 10.2105/ajph.83.8.1166

Source DB:  PubMed          Journal:  Am J Public Health        ISSN: 0090-0036            Impact factor:   9.308


  28 in total

1.  Hemorrhage in the newborn and vitamin K prophylaxis.

Authors:  K W WEFRING
Journal:  J Pediatr       Date:  1962-11       Impact factor: 4.406

2.  Use of oral vitamin K1 to prevent hemorrhagic disease of the newborn infant.

Authors:  M E O'Connor; J E Addiego
Journal:  J Pediatr       Date:  1986-04       Impact factor: 4.406

3.  Vitamin K in infancy.

Authors:  P A Lane; W E Hathaway
Journal:  J Pediatr       Date:  1985-03       Impact factor: 4.406

4.  Effect of vitamin K administration on acarboxy prothrombin (PIVKA-II) levels in newborns.

Authors:  K Motohara; F Endo; I Matsuda
Journal:  Lancet       Date:  1985-08-03       Impact factor: 79.321

5.  Severe vitamin K deficiency in breast-fed infants.

Authors:  K Motohara; M Matsukura; I Matsuda; K Iribe; T Ikeda; Y Kondo; A Yonekubo; Y Yamamoto; F Tsuchiya
Journal:  J Pediatr       Date:  1984-12       Impact factor: 4.406

6.  Plasma concentrations after oral or intramuscular vitamin K1 in neonates.

Authors:  A W McNinch; C Upton; M Samuels; M J Shearer; P McCarthy; J H Tripp; R L'E Orme
Journal:  Arch Dis Child       Date:  1985-09       Impact factor: 3.791

7.  Resurgence of hemorrhagic disease of the newborn: a report of three cases.

Authors:  B A Behrmann; W K Chan; N N Finer
Journal:  CMAJ       Date:  1985-11-01       Impact factor: 8.262

8.  Factor II (prothrombin) levels in cord blood: correlation of coagulant activity with immunoreactive protein.

Authors:  J J Corrigan; J J Kryc
Journal:  J Pediatr       Date:  1980-12       Impact factor: 4.406

Review 9.  Coagulation disorders in the neonate.

Authors:  G R Buchanan
Journal:  Pediatr Clin North Am       Date:  1986-02       Impact factor: 3.278

10.  Late presentation of haemorrhagic disease of the newborn.

Authors:  G Alpan; A Avital; O Peleg; Y Dgani
Journal:  Arch Dis Child       Date:  1984-05       Impact factor: 3.791

View more
  5 in total

Review 1.  Vitamin K supplementation to prevent hemorrhagic morbidity and mortality of newborns in India and China.

Authors:  Rajesh Kumar Rai; Jing Luo; Theodore Herzl Tulchinsky
Journal:  World J Pediatr       Date:  2016-11-15       Impact factor: 2.764

2.  Vitamin K and childhood cancer.

Authors:  S J Passmore; G J Draper; C A Stiller
Journal:  BMJ       Date:  1993-10-30

Review 3.  Vitamin K nutrition, metabolism, and requirements: current concepts and future research.

Authors:  Martin J Shearer; Xueyan Fu; Sarah L Booth
Journal:  Adv Nutr       Date:  2012-03-01       Impact factor: 8.701

4.  Controversies surrounding the administration of vitamin K to newborns: a review.

Authors:  M A Brousson; M C Klein
Journal:  CMAJ       Date:  1996-02-01       Impact factor: 8.262

Review 5.  Current concepts and controversies in the use of vitamin K.

Authors:  J A Thorp; L Gaston; D R Caspers; M L Pal
Journal:  Drugs       Date:  1995-03       Impact factor: 9.546

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.